Clinical Trial Update: Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sorafenib therapy before radiofrequency ablation for intermediate-sized hepatocellular carcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Hepatocellular Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-06-22